HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janina Remy Selected Research

DEVDase

7/2015Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janina Remy Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 07/2015
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 09/2020
1Brain Neoplasms (Brain Tumor)
09/2020
1Leukemia
07/2015
1Glioma (Gliomas)
07/2015

Drug/Important Bio-Agent (IBA)

2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2022 - 07/2015
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1ABT-737IBA
07/2015
1Sorafenib (BAY 43-9006)FDA Link
07/2015
1DEVDaseIBA
07/2015
1Transcription Factors (Transcription Factor)IBA
07/2015
1Cytochromes c (Cytochrome c)IBA
07/2015

Therapy/Procedure

1Therapeutics
01/2022
1Radiotherapy
09/2020
1Drug Therapy (Chemotherapy)
09/2020